Characterization of Infecting Strains and Superantigen-Neutralizing Antibodies in Staphylococcus aureus Bacteremia
- 1 March 2011
- journal article
- clinical trial
- Published by American Society for Microbiology in Clinical and Vaccine Immunology
- Vol. 18 (3) , 487-493
- https://doi.org/10.1128/cvi.00329-10
Abstract
Staphylococcus aureus superantigens (SAgs) are highly potent T cell mitogens. Antibodies against non-enterotoxin gene cluster (non-egc) SAgs are common in healthy adults, whereas neutralizing antibodies against egc SAgs are rare. We investigated the infecting S. aureus strains and the anti-SAg antibody response during S. aureus bacteremia (SAB). This prospective clinical study (www.clinicaltrials.gov, NCT00548002) included 43 injection drug users (IDUs) and 44 group-matched nonaddicts with SAB. spa genotypes and SAg gene patterns (multiplex PCR) of the S. aureus isolates were determined. The neutralizing capacities of sera obtained at the acute phase and the convalescent phase of SAB were tested against the SAg cocktail of the respective infecting strain and a panel of recombinant SAgs. The lineages CC59 and CC30 were more prevalent among bacteremia strains from IDUs than among strains from nonaddicts. SAg gene patterns in isolates from IDUs and nonaddicts were similar. At the acute phase of bacteremia, IDUs had more neutralizing antibodies against non-egc SAgs than did nonaddicts. Antibody titers frequently increased during infection. In contrast, there were no neutralizing antibodies against egc SAgs at disease onset and such antibodies were not induced by SAB. SAB triggers an antibody response only against non-egc SAgs. Preimmunization in IDU patients is probably due to previous exposure to the infecting strain.Keywords
This publication has 52 references indexed in Scilit:
- Association of Recurrent Furunculosis with Panton-Valentine Leukocidin and the Genetic Background of Staphylococcus aureusJournal of Clinical Microbiology, 2010
- Molecular epidemiology of Staphylococcus aureus in asymptomatic carriersEuropean Journal of Clinical Microbiology & Infectious Diseases, 2009
- Identification and Characterization of Two Novel Staphylococcal Enterotoxins, Types S and TInfection and Immunity, 2008
- Clonal Distribution of Superantigen Genes in ClinicalStaphylococcus aureusIsolatesJournal of Clinical Microbiology, 2007
- Assignment of Staphylococcus Isolates to Groups by spa Typing, SmaI Macrorestriction Analysis, and Multilocus Sequence TypingJournal of Clinical Microbiology, 2006
- Understanding the rise of the superbug: investigation of the evolution and genomic variation of Staphylococcus aureusFunctional & Integrative Genomics, 2006
- Staphylococcus aureus EndocarditisJAMA, 2005
- Superantigen Vaccines: A Comparative Study of Genetically Attenuated Receptor-Binding Mutants of Staphylococcal Enterotoxin AThe Journal of Infectious Diseases, 1996
- Immune Response to Toxic-Shock-Syndrome Toxin-1 (TSST-1) and to Staphylococcal Enterotoxins A, B and C in Staphylococcus aureus InfectionsZentralblatt für Bakteriologie, 1989
- Prevalence of Serum Antibodies to Toxic-Shock-Syndrome-Toxin-1 and to Staphylococcal Enterotoxins A, B and C in West-GermanyZentralblatt für Bakteriologie, Mikrobiologie und Hygiene. Series A: Medical Microbiology, Infectious Diseases, Virology, Parasitology, 1988